 - To evaluate the feasibility and safety of vaccination with cytomegalovirus CMV pp65-lysosomal-associated membrane protein LAMP mRNA-loaded dendritic cells DCs during recovery from therapeutic temozolomide-induced lymphopenia with or without autologous lymphocyte transfer ALT in patients with newly diagnosed glioblastoma multiforme and who are seropositive or seronegative for CMV. 